INS and Hypoglycemia: Insulin administration lowered tail-vein blood glucose to 35.33 ± 6.7 mg/dl; hence, core plasma glucose level (approximately 10 mg/dL higher than that measured from tail vein samples) was approximately 45 mg/dL, in line with our targeted hypoglycemia range [37].